ACERCA DE ESTE PODCAST 🔗

Presentadores:
Frecuencia de actualización:
daily
Duración media del audio:
29 minutes
Entrevistas a invitados
Inglés
Estados Unidos
269 episodios
desde 1 de enero de 1970
episodic

ÚLTIMO EPISODIO 🔗

We were delighted to be joined by Dr. Sam Blackman, a physician-scientist, biotech entrepreneur and investor who has built a fascinating career across medicine, drug development and biotechnology. Sam trained as a physician and spent much of his early career focused on pediatric oncology before mov…

BUSCAR EPISODIOS ANTERIORES

Buscar episodios anteriores de The BioHub - by Avetix.

EPISODIOS ANTERIORES

We were delighted to be joined by two highly experienced leaders in the biotechnology industry, Howard Berman, Ph.D., and Kia Motesharei, Ph.D. Both Howard and Kia have built impressive careers across biotechnology, capital markets, business development and strategic transactions, with a track reco…
In this episode of The BioHub Podcast, Ben sits down with Dr. Inder Kaul, Chief Medical Officer at Draig Therapeutics, to discuss the evolution of neuropsychiatric drug development and what it takes to translate novel neuroscience into meaningful medicines for patients. Inder brings decades of glob…
In this episode of The BioHub by Avetix, I’m joined by Eran Seger, CEO and Co-Founder of Protai. Eran shares his unique journey into biotech and the inspiration behind founding Protai, where the team is combining proteomics and AI to better understand disease biology and improve how new medicines …
We welcomed Mandana Honu onto the BioHub podcast
In this episode of The BioHub Podcast, Ben is joined by Dr. Marc Hedrick, President & CEO of Cerenome, and Russell Bradley, President & General Manager of CNSide Diagnostics. We explore why CNS cancers remain so difficult to diagnose and treat, and how Cerenome is attempting to address both…
In this episode of The BioHub by Avetix, I’m joined by Dan O’Connell, President and CEO of Acumen Pharmaceuticals. Dan shares his journey from neuroscience investing and company creation into the CEO role, and how he has helped take Acumen from a private, preclinical biotech into a publicly traded…
In this episode of The BioHub by Avetix, I’m joined by Paul Hastings, CEO of Nkarta. Paul has spent more than three decades in biotech, leading companies across oncology, rare disease and cell therapy, while also becoming one of the industry’s most prominent patient advocates. At Nkarta, he’s now …
We welcomed Lei Fang the CEO of Excalipoint to the BioHub
Today we’re joined by Jay Fine, President of Research & Development at EvolveImmune Therapeutics. Jay has spent more than 30 years working across drug discovery and development, with a career spanning immunology, immuno-oncology, inflammatory diseases and respiratory disorders. Before joining E…
Descargo de responsabilidad: El podcast y el arte incluidos en esta página son de Max Brennan - Biotech HeadHunter, que es propiedad de su propietario y no está afiliado ni respaldado por Listen Notes, Inc.